Neutrophil-Derived Myeloperoxidase Aggravates Non-Alcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Deficient Mice
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic inflammation and oxidative stress play fundamental roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). Previously, we reported that myeloperoxidase (MPO), an aggressive oxidant-generating neutrophil enzyme, is associated with NASH severity in man. We now investigated the hypothesis that MPO contributes to the development and progression of NASH. METHODOLOGY: Low-density lipoprotein receptor-deficient mice with an MPO-deficient hematopoietic system (LDLR(-/-/)MPO(-/-tp) mice) were generated and compared with LDLR(-/-/)MPO(+/+tp) mice after induction of NASH by high-fat feeding. RESULTS: High-fat feeding caused a ~4-fold induction of liver MPO in LDLR(-/-/)MPO(+/+) mice which was associated with hepatic sequestration of MPO-positive neutrophils and high levels of nitrotyrosine, a marker of MPO activity. Importantly, LDLR(-/-/)MPO(-/-tp) mice displayed markedly reduced hepatic neutrophil and T-lymphocyte infiltration (p<0.05), and strong down regulation of pro-inflammatory genes such as TNF-α and IL-6 (p<0.05, p<0.01) in comparison with LDLR(-/-/)MPO(+/+tp) mice. Next to the generalized reduction of inflammation, liver cholesterol accumulation was significantly diminished in LDLR(-/-/)MPO(-/-tp) mice (p = 0.01). Moreover, MPO deficiency appeared to attenuate the development of hepatic fibrosis as evident from reduced hydroxyproline levels (p<0.01). Interestingly, visceral adipose tissue inflammation was markedly reduced in LDLR(-/-/)MPO(-/-tp) mice, with a complete lack of macrophage crown-like structures. In conclusion, MPO deficiency attenuates the development of NASH and diminishes adipose tissue inflammation in response to a high fat diet, supporting an important role for neutrophils in the pathogenesis of metabolic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Myeloperoxidases secreted by neutrophils are associated with steatosis and inflammation.102”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Moreover, lipid peroxidation is known to be markedly elevated in adipose tissue of obese mice [38].”
BackgroundResultNonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · cited 1×
“Hepatic inflammation is one of the defining criteria in the diagnosis of NASH, and primarily characterized by the abundant presence of neutrophils [26].”
BackgroundCinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282 · cited 2×
“These phagocytes are notorious for their ability to induce tissue damage through generation of aggressive oxidants, which is largely mediated by the myeloperoxidase (MPO) enzyme [6,7].”
BackgroundNonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 764
Zheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Control of matrix metalloproteinase catalytic activity
Ra, H.-J., & Parks, W. C. (2007) · Matrix Biology · doi:10.1016/j.matbio.2007.07.001 · Cited by 647
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J. C., & García-Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 608
Cited by
Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function
Aratani, Y. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.01.004 · Cited by 943
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
Neutrophils in chronic inflammatory diseases
Herrero-Cervera, A., Soehnlein, O., & Kenne, E. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00832-3 · Cited by 695
Innate Immunity and Inflammation in NAFLD/NASH
Arrese, M., Cabrera, D., Kalergis, A. M., & Feldstein, A. E. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4049-x · Cited by 492
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Parthasarathy, G., Revelo, X., & Malhi, H. (2020) · Hepatology Communications · doi:10.1002/hep4.1479 · Cited by 414
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Spahis, S., Delvin, E., Borys, J.-M., & Levy, E. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6776 · Cited by 386
The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease
Davies, M. J., & Hawkins, C. L. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8030 · Cited by 332
Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
Marjot, T., Moolla, A., Cobbold, J. F., Hodson, L., & Tomlinson, J. W. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz009 · Cited by 228
Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system
Honda, M., & Kubes, P. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.183 · Cited by 227
The role of neutrophils in the development of liver diseases
Xu, R., Huang, H., Zhang, Z., & Wang, F.-S. (2014) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.2 · Cited by 226
Molecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 209
Luci, C., Bourinet, M., Leclère, P. S., Anty, R., & Gual, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.597648 · Cited by 195
Guo, Q., Furuta, K., Lucien, F., Gutierrez Sanchez, L. H., Hirsova, P., Krishnan, A., Kabashima, A., Pavelko, K. D., Madden, B., Alhuwaish, H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.07.019 · Cited by 181
Farrell, G. C., Haczeyni, F., & Chitturi, S. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-8684-7_3 · Cited by 178
Vitamin D: A new player in non-alcoholic fatty liver disease?
Eliades, M., & Spyrou, E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1718 · Cited by 181
Neutrophils in Physiology and Pathology
Aroca-Crevillén, A., Vicanolo, T., Ovadia, S., & Hidalgo, A. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-015009 · Cited by 170
Pulli, B., Ali, M., Iwamoto, Y., Zeller, M. W. G., Schob, S., Linnoila, J. J., & Chen, J. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6108 · Cited by 143
“Recently, it was reported that human livers with NASH contain higher amounts of MPO compared with steatotic specimens (41), and that chimeric LDLR - / - mice with an MPO-deficient hematopoietic system have decreased inflammation and fibrosis in a high-fat diet-induced disease model of NASH (40).”
Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice
Bijnen, M., Josefs, T., Cuijpers, I., Maalsen, C. J., van de Gaar, J., Vroomen, M., Wijnands, E., Rensen, S. S., Greve, J. W. M., Hofker, M. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313654 · Cited by 134
Self-citationNati, M., Haddad, D., Birkenfeld, A. L., Koch, C. A., Chavakis, T., & Chatzigeorgiou, A. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9339-2 · Cited by 147
Tomita, K., Freeman, B. L., Bronk, S. F., LeBrasseur, N. K., White, T. A., Hirsova, P., & Ibrahim, S. H. (2016) · Scientific Reports · doi:10.1038/srep28786 · Cited by 127
Reiniers, M. J., van Golen, R. F., van Gulik, T. M., & Heger, M. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5486 · Cited by 128
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Barrow, F., Khan, S., Wang, H., & Revelo, X. S. (2021) · Hepatology · doi:10.1002/hep.31889 · Cited by 126
Understanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
Zhang, P.-W., Chen, F.-X., Li, D., Ling, W.-H., & Guo, H.-H. (2015) · Medicine · doi:10.1097/md.0000000000000758 · Cited by 116
Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Li, H., Zhou, Y., Wang, H., Zhang, M., Qiu, P., Zhang, M., Zhang, R., Zhao, Q., & Liu, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01169 · Cited by 114
CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease
Breuer, D. A., Pacheco, M. C., Washington, M. K., Montgomery, S. A., Hasty, A. H., & Kennedy, A. J. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00040.2019 · Cited by 113
Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
Delporte, C., Van Antwerpen, P., Vanhamme, L., Roumeguère, T., & Zouaoui Boudjeltia, K. (2013) · Mediators of Inflammation · doi:10.1155/2013/971579 · Cited by 107
The Roles of Neutrophils in the Pathogenesis of Liver Diseases
Tang, J., Yan, Z.-J., Feng, Q., Yu, L., & Wang, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.625472 · Cited by 108
The Role of Myeloid-Derived Cells in the Progression of Liver Disease
Weston, C. J., Zimmermann, H. W., & Adams, D. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00893 · Cited by 95
IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Giles, D., Moreno-Fernandez, M., & Divanovic, S. (2015) · Current Drug Targets · doi:10.2174/1389450116666150531153627 · Cited by 95
Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease
Monserrat-Mesquida, M., Quetglas‐Llabrés, M. M., Abbate, M., Montemayor, S., Mascaró, C. M., Casares, M., Tejada, S., Abete, I., Zulet, M. Á., Tur, J. A., et al. (2020) · Antioxidants · doi:10.3390/antiox9080759 · Cited by 107
Joshi-Barve, S., Kirpich, I., Cave, M. C., Marsano, L. S., & McClain, C. J. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.05.006 · Cited by 89
Atanasovska, B., Rensen, S. S., van der Sijde, M. R., Marsman, G., Kumar, V., Jonkers, I. H., Withoff, S., Shiri‐Sverdlov, R., Greve, J. W. M., Faber, K. N., et al. (2017) · Hepatology · doi:10.1002/hep.29034 · Cited by 91
Self-citationRole of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
Hwang, S., Yun, H., Moon, S., Cho, Y. E., & Gao, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.751802 · Cited by 84
Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice
Ou, R., Liu, J., Lv, M., Wang, J., Wang, J., Zhu, L. Y., Zhao, L., & Xu, Y. (2017) · Endocrine · doi:10.1007/s12020-017-1323-4 · Cited by 79
The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease
Nati, M., Chung, K.-J., & Chavakis, T. (2022) · Journal of Innate Immunity · doi:10.1159/000518407 · Cited by 71
Hirsova, P., Bamidele, A. O., Wang, H., Povero, D., & Revelo, X. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.760860 · Cited by 70
Hepatic Macrophage as a Key Player in Fatty Liver Disease
Xu, L., Liu, W., Bai, F., Xu, Y., Liang, X., Ma, C., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708978 · Cited by 76
Immunomodulatory functions of FXR
Fiorucci, S., Zampella, A., Ricci, P., Distrutti, E., & Biagioli, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111650 · Cited by 70
The immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
“Consequently, it is not surprising that deficiency of MPO results in a marked reduction in the production of pro-inflammatory cytokines and development of hepatic fibrosis (52,54).”
BackgroundSchwingel, T. E., Klein, C. P., Nicoletti, N. F., Dora, C. L., Hädrich, G., Bica, C. G., Lopes, T. G., da Silva, V. D., & Morrone, F. B. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-0994-0 · Cited by 71
Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
Vonghia, L., Michielsen, P., & Francque, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019867 · Cited by 64
Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine
Kim, H. W., Blomkalns, A. L., Ogbi, M., Thomas, M., Gavrila, D., Neltner, B. S., Cassis, L. A., Thompson, R. W., Weiss, R. M., Lindower, P. D., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00296.2017 · Cited by 63
Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease
Byun, J., & Yi, H. (2017) · BioMed Research International · doi:10.1155/2017/6862439 · Cited by 63
Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis
Schneider, K. M., Mohs, A., Kilic, K., Candels, L. S., Elfers, C., Bennek, E., Schneider, L. B., Heymann, F., Gaßler, N., Penders, J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020308 · Cited by 64
Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease
Bartneck, M., & Wang, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02257 · Cited by 60
Advances in functional and molecular MRI technologies in chronic liver diseases
Zhou, I. Y., Catalano, O. A., & Caravan, P. D. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.06.020 · Cited by 63
Wang, Y., & Liu, Y. (2021) · Inflammation · doi:10.1007/s10753-021-01442-x · Cited by 71
Treating inflammation to combat non-alcoholic fatty liver disease
Wiering, L., & Tacke, F. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0194 · Cited by 56
Wu, L., Gao, X., Guo, Q., Li, J., Yao, J., Yan, K., Xu, Y., Jiang, X. X., Ye, D., & Guo, J. (2020) · Hepatology International · doi:10.1007/s12072-020-10081-7 · Cited by 59
Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders
Hassan, W., Ding, L., Gao, R.-Y., Liu, J., & Shang, J. (2014) · Cytokine · doi:10.1016/j.cyto.2013.12.017 · Cited by 60
Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis
Segers, F. M., Verdam, F. J., de Jonge, C., Boonen, B., Driessen, A., Shiri-Sverdlov, R., Bouvy, N. D., Greve, J. W. M., Buurman, W. A., & Rensen, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110053 · Cited by 50
Self-citationArelaki, S., Κoletsa, T., Sinakos, E., Papadopoulos, V. P., Arvanitakis, K., Skendros, P., Akriviadis, E. A., Ritis, K., Germanidis, G. S., & Hytiroglou, P. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-022-03330-7 · Cited by 52
Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice
Koop, A. C., Thiele, N. D., Steins, D., Michaëlsson, E., Wehmeyer, M., Scheja, L., Steglich, B., Huber, S., Schulze zur Wiesch, J., Lohse, A. W., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1566 · Cited by 48
Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma
Koo, S.-Y., Park, E.-J., & Lee, C.-W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0480-3 · Cited by 47
Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis
Méndez‐Sánchez, N., Córdova‐Gallardo, J., Barranco-Fragoso, B., & Eslam, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641240 · Cited by 52
Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
Hundertmark, J., Krenkel, O., & Tacke, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02418 · Cited by 44
Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy
Chen, K., Yuan, R., Zhang, Y., Geng, S., & Li, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004078 · Cited by 44
Stress kinases in the development of liver steatosis and hepatocellular carcinoma
Cicuéndez, B., Ruiz-Garrido, I., Mora, A., & Sabio, G. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101190 · Cited by 48
Ishay, Y., Nachman, D., Khoury, T., & Ilan, Y. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00003.2020 · Cited by 42
Chatzigeorgiou, A., & Chavakis, T. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_8 · Cited by 50
Pulli, B., Wojtkiewicz, G. R., Iwamoto, Y., Ali, M. Y. J., Zeller, M. W. G., Buré, L., Wang, C., Choi, Y., Masia, R., Guimarães, A. R., et al. (2017) · Radiology · doi:10.1148/radiol.2017160588 · Cited by 42
Morandini, L., Avery, D., Angeles, B., Winston, P., Martin, R. K., Donahue, H. J., & Olivares-Navarrete, R. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.016 · Cited by 40
The immune response as a therapeutic target in non-alcoholic fatty liver disease
Ortiz‐López, N., Fuenzalida, C., Dufeu, M. S., Pinto-León, A., Escobar, A. F., Poníachik, J., Roblero, J. P., Valenzuela-Pérez, L., & Beltrán, C. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954869 · Cited by 40
Antonucci, L., Porcu, C., Timperi, E., Santini, S. J., Iannucci, G., & Balsano, C. (2020) · Journal of Immunology Research · doi:10.1155/2020/4570219 · Cited by 34
Biagioli, M., & Fiorucci, S. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.003 · Cited by 37
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC
Wu, Q., Yang, Y., Lin, S., Geller, D. A., & Yan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1569915 · Cited by 32
Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.
Ramadori, P., Kroy, D. C., & Streetz, K. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.01.02 · Cited by 32
Gwag, T., Ma, E., Zhou, C., & Wang, S. (2022) · Liver International · doi:10.1111/liv.15182 · Cited by 33
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
Santos‐Laso, Á., Gutiérrez‐Larrañaga, M., Alonso‐Peña, M., Medina, J. M., Iruzubieta, P., Arias, M., López‐Hoyos, M., & Crespo, J. (2021) · Biomedicines · doi:10.3390/biomedicines10010046 · Cited by 40
Shrestha, S., Jeon, J.-H., & Hong, C.-W. (2025) · BMB Reports · doi:10.5483/bmbrep.2024-0058 · Cited by 30
Marqués, P., Francisco, V., Martínez‐Arenas, L., Carvalho‐Gomes, Â., Domingo, E., Piqueras, L., Berenguer, M., & Sanz, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032313 · Cited by 32
Zhang, Y., Zhou, X., Liu, P., Chen, X., Zhang, J., Zhang, H., Li, S., Chen, Y., Song, X., Wang, J., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00342.2020 · Cited by 33
The role of platelet mediated thromboinflammation in acute liver injury
Morris, S. M., & Chauhan, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1037645 · Cited by 31
Angioni, R., Calì, B., Vigneswara, V., Crescenzi, M., Merino, A. M., Sánchez‐Rodríguez, R., Liboni, C., Hoogduijn, M. J., Newsome, P. N., Muraca, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228874 · Cited by 28
L-Selectin/CD62L Is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men
Drescher, H. K., Schippers, A., Rosenhain, S., Gremse, F., Bongiovanni, L., de Bruin, A., Eswaran, S., Gallage, S., Pfister, D. R., Szydlowska, M., et al. (2020) · Cells · doi:10.3390/cells9051106 · Cited by 29
Chen, S., Guo, H., Xie, M., Zhou, C., & Zheng, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107609 · Cited by 26
Kucsera, D., Tóth, V. É., Sayour, N. V., Kovács, T., Gergely, T. G., Ruppert, M., Radovits, T., Fábián, A., Kovács, A. D., Merkely, B. P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-26896-3 · Cited by 31
Vonghia, L., Herck, M. A. V., Weyler, J., & Francque, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00563 · Cited by 25
Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Ma, D. W., Ha, J., Yoon, K., Kang, I., Choi, T. G., & Kim, S. S. (2023) · Nutrients · doi:10.3390/nu15092068 · Cited by 27
Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice
Bijnen, M., Josefs, T., Cuijpers, I., van de Gaar, J., Vroomen, M. A. M., Wijnands, E., Rensen, S. S., Greve, J. W. M., Hofker, M. H., Biessen, E. A. L., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31630-6 · Cited by 22
Self-citationThymus fontanesii attenuates CCl4-induced oxidative stress and inflammation in mild liver fibrosis
Abdelghffar, E. A. R., Obaid, W. A., Alamoudi, M. O., Mohammedsaleh, Z. M., Annaz, H., Abdelfattah, M. A. O., & Sobeh, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112738 · Cited by 25
Lu, Y., Xu, X., Wu, J., Ji, L., Huang, H., & Chen, M. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03394-6 · Cited by 22
Feng, D. (2020) · Liver Research · doi:10.1016/j.livres.2020.02.003 · Cited by 18
Myeloid cells in chronic liver inflammation
Patseas, D., El-Masry, A., Liu, Z., Ramachandran, P., & Triantafyllou, E. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01324-4 · Cited by 22
Ji, W., & Zhang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22330 · Cited by 18
Li, J., Yin, L., Chen, S., Li, Z., Ding, J., Wu, J., Yang, K., & Xu, J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1221361 · Cited by 18
Alshammari, G. M., Balakrishnan, A., & Chinnasamy, T. (2017) · Inflammation Research · doi:10.1007/s00011-017-1054-2 · Cited by 16
Neutrophil traps, anti-myeloperoxidase antibodies and cancer: Are they linked?
Scandolara, T. B., & Panis, C. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.02.011 · Cited by 19
Amano, Y., Shimizu, F., Yasuno, H., Harada, A., Tsuchiya, S., Isono, O., Nagabukuro, H., & Tozawa, R. (2016) · Hepatology Research · doi:10.1111/hepr.12709 · Cited by 15
Lee, H., Lee, Y., Chung, C., Park, S., Shin, H. J., Joe, E.-H., Lee, S. J., Kim, D. W., Jo, S., & Choi, S. (2024) · Glia · doi:10.1002/glia.24629 · Cited by 15
Xu, L., Liu, X., Jia, T., Sun, Y., Du, Y., Wei, S., Wang, W., Zhang, Y., Chen, W., & Zhang, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5769350 · Cited by 13
Zhou, Z., Li, L., Wang, C., Li, S., Chen, P., Huang, J., & Peng, M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1579453 · Cited by 17
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis
Chung, K. W., Cho, Y. E., Kim, S.-J., & Hwang, S. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01379-1 · Cited by 11
Aguilar, E. C., Fernandes‐Braga, W., Leocádio, P. C. L., Campos, G. P., Lemos, V. S., de Oliveira, R. P., Faria, A. M. C., Capettini, L. D. S. A., & Alvarez-Leite, J. I. (2023) · Food & Function · doi:10.1039/d3fo00149k · Cited by 9
Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced Lipolysis
Maraga, E., Safadi, R., Amer, J., Higazi, A. A., & Fanne, R. A. (2023) · Medicina · doi:10.3390/medicina59050983 · Cited by 7
Lu, Z., Li, Y., Li, A., Syn, W., Wank, S. A., Lopes-Virella, M. F., & Huang, Y. Q. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277251 · Cited by 8
Li, G., Park, H. J., Suh, J., & Choi, H. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109552 · Cited by 7
Human Neutrophil α-Defensins 1–3 Are Upregulated in the Microenvironment of Fibrotic Liver
Fanne, R. A., Maraga, E., Kassem, E., Groisman, G. M., Amsalem, N., Zeina, A., Mouch, M. A., Taher, R., & Abu‐Mouch, S. (2023) · Medicina · doi:10.3390/medicina59030496 · Cited by 6
Metadata
- Authors
- Rensen, S. S., Bieghs, V., Xanthoulea, S., Arfianti, E., Bakker, J. A., Shiri-Sverdlov, R., Hofker, M. H., Greve, J. W., & Buurman, W. A.
- Affiliations
- Maastricht University Medical Centre (NL)
- University Medical Center Groningen (NL)
- Corresponding author
- Rensen, Sander S.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-20
- Volume
- 7
- Issue
- 12
- Pages
- e52411
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3527496
- OpenAlex
- W2004807994
- Cited by
- 116
- References
- 47
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 13 · 2021: 15 · 2020: 17 · 2019: 8 · 2018: 7 · 2017: 10 · 2016: 8 · 2015: 8 · 2014: 4 · 2013: 3
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Transnationale Universiteit Limburg
- SenterNovem
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- myeloperoxidase, nonalcoholic steatohepatitis, neutrophils, Ldlr-deficient mice, liver inflammation, oxidative stress, nitrotyrosine, liver fibrosis, visceral adipose tissue inflammation, high-fat diet, TNF-α, interleukin-6, metabolic disorders
- MeSH terms
- Adipose Tissue, Animals, Cholesterol, Enzyme Induction, Fatty Liver, Feeding Behavior, Humans, Inflammation, Liver, Liver Cirrhosis, Mice, Inbred C57BL, Peroxidase, Neutrophils, Receptors, LDL, Triglycerides, Mice, Diet, High-Fat, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.